SCHEMBL4689784

SCHEMBL4689784

NCCCCC(C(=O)O)N(CCO)CCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.47
RNPEP Q9H4A4 1/20 0.46
CPB2 Q96IY4 7/20 0.42
FOLH1 Q04609 1/20 0.37
CYP2D6 P10635 1/20 0.34
NFKB1 P19838 1/20 0.34
CPB1 P15086 1/20 0.33
BLM P54132 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PLG P00747 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33
SLC6A2 P23975 1/20 0.33
RECQL P46063 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KMT2A Q03164 1/20 0.33
EPOR P19235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4689786 1.00 GSR (0.47) GSRRNPEPCPB2FOLH1CYP2D6
SCHEMBL6859337 0.89 GSR (0.50) GSRRNPEPCPB2FOLH1CYP2D6
SCHEMBL6859332 0.89 GSR (0.50) GSRRNPEPCPB2FOLH1CYP2D6
SCHEMBL11578897 0.85 GSR (0.50) GSRRNPEPCPB2FOLH1CYP2D6
SCHEMBL11578907 0.85 GSR (0.50) GSRRNPEPCPB2FOLH1CYP2D6
SCHEMBL28816367 0.84 CPB2 (0.37) GSRRNPEPCPB2FOLH1CYP2D6
SCHEMBL4300231 0.84 GSR (0.46) GSRRNPEPCPB2FOLH1NOD1
Lysepsin A SCHEMBL9012919 0.84 GSR (0.46) GSRRNPEPCPB2FOLH1CYP2D6
SCHEMBL4300233 0.84 GSR (0.46) GSRRNPEPCPB2FOLH1NOD1
SCHEMBL3361894 0.82 NOD1 (0.40) GSRRNPEPCPB2FOLH1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020217116-A2 LONG ACTING INHALATION COMPOSITIONS OF INDACATEROL ORBICULAR PHARMACEUTICAL TECHNOLOGIES PVT LTD (IN) 2020-10-29 WO disclosed
US-7462645-B2 Bronchodilating beta-agonist compositions and methods JPMORGAN CHASE BANK, N.A. (US) 2008-12-09 US disclosed